ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 160 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $2,561,000 | -5.3% | 237,155 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $2,704,000 | +25.2% | 237,155 | 0.0% | 0.00% | +100.0% |
Q1 2022 | $2,160,000 | -38.9% | 237,155 | 0.0% | 0.00% | -50.0% |
Q4 2021 | $3,538,000 | -42.0% | 237,155 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $6,095,000 | -1.5% | 237,155 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $6,185,000 | -26.2% | 237,155 | -0.1% | 0.01% | -33.3% |
Q1 2021 | $8,379,000 | -30.0% | 237,353 | -50.0% | 0.01% | +33.3% |
Q4 2020 | $11,972,000 | +33.9% | 474,310 | +100.0% | 0.01% | -43.8% |
Q3 2020 | $8,943,000 | -11.9% | 237,155 | 0.0% | 0.02% | -23.8% |
Q2 2020 | $10,155,000 | +120.3% | 237,155 | 0.0% | 0.02% | +90.9% |
Q1 2020 | $4,610,000 | – | 237,155 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 1,798,163 | $5,700,177 | 8.82% |
Wildcat Capital Management, LLC | 1,920,787 | $6,088,895 | 2.44% |
TPG GP A, LLC | 18,716,306 | $59,330,690 | 1.02% |
EcoR1 Capital, LLC | 4,488,200 | $14,227,594 | 0.48% |
CROSSPOINT FINANCIAL, LLC | 12,000 | $38,040 | 0.40% |
Coastal Bridge Advisors, LLC | 406,847 | $1,289,705 | 0.35% |
CAXTON ASSOCIATES LP | 480,104 | $1,521,930 | 0.21% |
Woodline Partners LP | 5,313,915 | $16,845,111 | 0.20% |
Rhenman & Partners Asset Management AB | 300,000 | $951,000 | 0.10% |
Navalign, LLC | 75,365 | $238,907 | 0.09% |